κB-Ras proteins regulate both NF-κB-dependent inflammation and Ral-dependent proliferation

Cell Reports

Volumn 8, Issue 6, 2014, Pages 1793-1807

  Oeckinghaus, Andrea ^a,d   Postler, Thomas S ^a   Rao, Ping ^a,e   Schmitt, Heike ^a   Schmitt, Verena ^a   Grinberg Bleyer, Yenkel ^a   Kühn, Lars I ^a,f   Gruber, Christian W ^b   Lienhard, Gustav E ^c   Ghosh, Sankar ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAPPA B RAS PROTEIN; KAPPA B RAS1 PROTEIN; KAPPA B RAS2 PROTEIN; RAL PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG; CYCLINE; I KAPPA B;

ANCHORAGE INDEPENDENT GROWTH; ANCHORAGE INDEPENDENT PROLIFERATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATION; LUNG DEVELOPMENT; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PERINATAL MORTALITY; PROTEIN PROTEIN INTERACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DEFICIENCY; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; LUNG; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROLIFERATING CELL NUCLEAR ANTIGEN; RAL GTP-BINDING PROTEINS; RAS PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84907389633     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.015     Document Type: Article

References (69)

1. Bachurski C.J., Pryhuber G.S., Glasser S.W., Kelly S.E., Whitsett J.A. Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J.Biol. Chem. 1995, 270:19402-19407.
2. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., Schinzel A.C., Sandy P., Meylan E., Scholl C., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112.
3. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
4. Bodemann B.O., White M.A. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 2008, 8:133-140.
5. Bodempudi V., Yamoutpoor F., Pan W., Dudek A.Z., Esfandyari T., Piedra M., Babovick-Vuksanovic D., Woo R.A., Mautner V.F., Kluwe L., et al. Ral overactivation in malignant peripheral nerve sheath tumors. Mol. Cell. Biol. 2009, 29:3964-3974.
6. Bos J.L., Rehmann H., Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007, 129:865-877.
7. Chen Y., Wu J., Ghosh G. KappaB-Ras binds to the unique insert within the ankyrin repeat domain of IkappaBbeta and regulates cytoplasmic retention of IkappaBbeta x NF-kappaB complexes. J.Biol. Chem. 2003, 278:23101-23106.
8. Chen Y., Vallee S., Wu J., Vu D., Sondek J., Ghosh G. Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras. Mol. Cell. Biol. 2004, 24:3048-3056.
9. Chen X.W., Leto D., Xiong T., Yu G., Cheng A., Decker S., Saltiel A.R. A Ral GAP complex links PI 3-kinase/Akt signaling to RalA activation in insulin action. Mol. Biol. Cell 2011, 22:141-152.
10. Cherfils J., Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol. Rev. 2013, 93:269-309.
11. Chien Y., White M.A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 2003, 4:800-806.
12. Chien Y., Kim S., Bumeister R., Loo Y.M., Kwon S.W., Johnson C.L., Balakireva M.G., Romeo Y., Kopelovich L., Gale M., et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006, 127:157-170.
13. Colicelli J. Human RAS superfamily proteins and related GTPases. Sci. STKE 2004, 2004:RE13.
14. Collette J., Ulku A.S., Der C.J., Jones A., Erickson A.H. Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells. Int. J. Cancer 2004, 112:190-199.
15. Cox A.D., Der C.J. Ras history: The saga continues. Small GTPases 2010, 1:2-27.
16. de Bruyn K.M., de Rooij J., Wolthuis R.M., Rehmann H., Wesenbeek J., Cool R.H., Wittinghofer A.H., Bos J.L. RalGEF2, a pleckstrin homology domain containing guanine nucleotide exchange factor for Ral. J.Biol. Chem. 2000, 275:29761-29766.
17. Feig L.A. Ral-GTPases: approaching their 15minutes of fame. Trends Cell Biol. 2003, 13:419-425.
18. Fenwick C., Na S.Y., Voll R.E., Zhong H., Im S.Y., Lee J.W., Ghosh S. A subclass of Ras proteins that regulate the degradation of IkappaB. Science 2000, 287:869-873.
19. Finak G., Bertos N., Pepin F., Sadekova S., Souleimanova M., Zhao H., Chen H., Omeroglu G., Meterissian S., Omeroglu A., et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008, 14:518-527.
20. Frerking I., Günther A., Seeger W., Pison U. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med. 2001, 27:1699-1717.
21. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 2001, 98:13784-13789.
22. Gerashchenko G.V., Bogatyrova O.O., Rudenko E.E., Kondratov A.G., Gordiyuk V.V., Zgonnyk Y.M., Vozianov O.F., Pavlova T.V., Zabarovsky E.R., Rynditch A.V., Kashuba V.I. Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas. Exp. Oncol. 2010, 32:71-75.
23. Gridley S., Chavez J.A., Lane W.S., Lienhard G.E. Adipocytes contain a novel complex similar to the tuberous sclerosis complex. Cell. Signal. 2006, 18:1626-1632.
24. Guruharsha K.G., Rual J.F., Zhai B., Mintseris J., Vaidya P., Vaidya N., Beekman C., Wong C., Rhee D.Y., Cenaj O., et al. A protein complex network of Drosophila melanogaster. Cell 2011, 147:690-703.
25. Hamad N.M., Elconin J.H., Karnoub A.E., Bai W., Rich J.N., Abraham R.T., Der C.J., Counter C.M. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 2002, 16:2045-2057.
26. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
27. Hayden M.S., Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
28. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
29. Jou Y.J., Lin C.D., Lai C.H., Chen C.H., Kao J.Y., Chen S.Y., Tsai M.H., Huang S.H., Lin C.W. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal. Chim. Acta 2010, 681:41-48.
30. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
31. Karnoub A.E., Weinberg R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 2008, 9:517-531.
32. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
33. Kim S.M., Park Y.Y., Park E.S., Cho J.Y., Izzo J.G., Zhang D., Kim S.B., Lee J.H., Bhutani M.S., Swisher S.G., et al. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS ONE 2010, 5:e15074.
34. Leto D., Uhm M., Williams A., Chen X.W., Saltiel A.R. Negative regulation of the RalGAP complex by 14-3-3. J.Biol. Chem. 2013, 288:9272-9283.
35. Lim K.H., Baines A.T., Fiordalisi J.J., Shipitsin M., Feig L.A., Cox A.D., Der C.J., Counter C.M. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 2005, 7:533-545.
36. Lim K.H., O'Hayer K., Adam S.J., Kendall S.D., Campbell P.M., Der C.J., Counter C.M. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 2006, 16:2385-2394.
37. Lin H., Wang Y., Zhang X., Liu B., Zhang W., Cheng J. Prognostic significance of kappaB-Ras1 expression in gliomas. Med. Oncol. 2012, 29:1272-1279.
38. Martin T.D., Samuel J.C., Routh E.D., Der C.J., Yeh J.J. Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res. 2011, 71:206-215.
39. Meylan E., Dooley A.L., Feldser D.M., Shen L., Turk E., Ouyang C., Jacks T. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009, 462:104-107.
40. Murat A., Migliavacca E., Gorlia T., Lambiv W.L., Shay T., Hamou M.F., de Tribolet N., Regli L., Wick W., Kouwenhoven M.C., et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J.Clin. Oncol. 2008, 26:3015-3024.
41. Oinuma I., Kawada K., Tsukagoshi K., Negishi M. Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation. Mol. Biol. Cell 2012, 23:1593-1604.
42. Peschard P., McCarthy A., Leblanc-Dominguez V., Yeo M., Guichard S., Stamp G., Marshall C.J. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis. Curr. Biol. 2012, 22:2063-2068.
43. Pryhuber G.S., Bachurski C., Hirsch R., Bacon A., Whitsett J.A. Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am. J. Physiol. 1996, 270:L714-L721.
44. Rangarajan A., Hong S.J., Gifford A., Weinberg R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 2004, 6:171-183.
45. Rao P., Hayden M.S., Long M., Scott M.L., West A.P., Zhang D., Oeckinghaus A., Lynch C., Hoffmann A., Baltimore D., Ghosh S. IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature 2010, 466:1115-1119.
46. Rebhun J.F., Chen H., Quilliam L.A. Identification and characterization of a new family of guanine nucleotide exchange factors for the ras-related GTPase Ral. J.Biol. Chem. 2000, 275:13406-13410.
47. Saito R., Shirakawa R., Nishiyama H., Kobayashi T., Kawato M., Kanno T., Nishizawa K., Matsui Y., Ohbayashi T., Horiguchi M., et al. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene 2013, 32:894-902.
48. Scheibel M., Klein B., Merkle H., Schulz M., Fritsch R., Greten F.R., Arkan M.C., Schneider G., Schmid R.M. IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription invivo. J.Exp. Med. 2010, 207:2621-2630.
49. Shao H., Andres D.A. A novel RalGEF-like protein, RGL3, asa candidate effector for rit and Ras. J.Biol. Chem. 2000, 275:26914-26924.
50. Shirakawa R., Fukai S., Kawato M., Higashi T., Kondo H., Ikeda T., Nakayama E., Okawa K., Nureki O., Kimura T., et al. Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases. J.Biol. Chem. 2009, 284:21580-21588.
51. Smith S.C., Oxford G., Wu Z., Nitz M.D., Conaway M., Frierson H.F., Hampton G., Theodorescu D. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res. 2006, 66:1917-1922.
52. Smith S.C., Oxford G., Baras A.S., Owens C., Havaleshko D., Brautigan D.L., Safo M.K., Theodorescu D. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin. Cancer Res. 2007, 13:3803-3813.
53. Smith S.C., Baras A.S., Owens C.R., Dancik G., Theodorescu D. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer. Cancer Res. 2012, 72:3480-3491.
54. Sun L., Hui A.M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9:287-300.
55. Tago K., Funakoshi-Tago M., Sakinawa M., Mizuno N., Itoh H. KappaB-Ras is a nuclear-cytoplasmic small GTPase that inhibits NF-kappaB activation through the suppression of transcriptional activation of p65/RelA. J.Biol. Chem. 2010, 285:30622-30633.
56. Tam W.F., Sen R. IkappaB family members function by different mechanisms. J.Biol. Chem. 2001, 276:7701-7704.
57. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., Ghosh S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 1995, 80:573-582.
58. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J.Cell Biol. 1963, 17:299-313.
59. Tran K., Merika M., Thanos D. Distinct functional properties of IkappaB alpha and IkappaB beta. Mol. Cell. Biol. 1997, 17:5386-5399.
60. Trompouki E., Tsagaratou A., Kosmidis S.K., Dollé P., Qian J., Kontoyiannis D.L., Cardoso W.V., Mosialos G. Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation. Neoplasia 2009, 11:469-476.
61. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 1996, 15:810-816.
62. Vigil D., Martin T.D., Williams F., Yeh J.J., Campbell S.L., Der C.J. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms. J.Biol. Chem. 2010, 285:34729-34740.
63. Weaver T.E., Conkright J.J. Function of surfactant proteins B and C. Annu. Rev. Physiol. 2001, 63:555-578.
64. Wennerberg K., Forget M.A., Ellerbroek S.M., Arthur W.T., Burridge K., Settleman J., Der C.J., Hansen S.H. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr. Biol. 2003, 13:1106-1115.
65. Wennerberg K., Rossman K.L., Der C.J. The Ras superfamily at a glance. J.Cell Sci. 2005, 118:843-846.
66. White M.A., Vale T., Camonis J.H., Schaefer E., Wigler M.H. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J.Biol. Chem. 1996, 271:16439-16442.
67. Wispé J.R., Clark J.C., Warner B.B., Fajardo D., Hull W.E., Holtzman R.B., Whitsett J.A. Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J.Clin. Invest. 1990, 86:1954-1960.
68. Wolthuis R.M., Bos J.L. Ras caught in another affair: the exchange factors for Ral. Curr. Opin. Genet. Dev. 1999, 9:112-117.
69. Young A., Lyons J., Miller A.L., Phan V.T., Alarcón I.R., McCormick F. Ras signaling and therapies. Adv. Cancer Res. 2009, 102:1-17.